NAFDAC Raises Alarm Over Counterfeit TANDAK Injection
The National Drug Law Enforcement Agency (NAFDAC) has issued a warning regarding the sale of counterfeit TANDAK injection 1.5g powder and water for injection, produced by Intracin Pharmaceuticals PVT. LTD in Gujarat, India.
According to a statement released by the agency on Wednesday, April 10, the counterfeit product was discovered in Gombe State, Nigeria, and reported to NAFDAC by Marcson Healthcare Ltd., the Marketing Authorization Holder (MAH).
TANDAK® injection of 1.5g powder is a combination of Ceftriaxone 1000mg and Sulbactam 500mg, prescribed for treating various bacterial infections. It works by inhibiting the growth and spread of microorganisms. The statement emphasized that Ceftriaxone+Sulbactam 1000mg/500mg Injection should only be administered under the supervision of a healthcare professional.
The illegal sale of counterfeit medicines poses serious health risks, as they may not meet regulatory standards for safety, quality, and efficacy.
NAFDAC has instructed its Zonal Directors and State Coordinators to conduct surveillance and remove counterfeit products from their respective areas.
Healthcare professionals and consumers are urged to report any suspected sale of substandard or falsified medicines or medical devices to the nearest NAFDAC office, call 0800-162-3322, or send an
email to [email protected].
